Citation Impact
Citing Papers
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
2021 Science
Elucidating Design Principles for Engineering Cell‐Derived Vesicles to Inhibit SARS‐CoV‐2 Infection
2022
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
2023
Zero‐shot mutation effect prediction on protein stability and function using RoseTTAFold
2023 StandoutNobel
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
2023 StandoutNobel
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Machine learning for functional protein design
2024
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Multistate and functional protein design using RoseTTAFold sequence space diffusion
2024 StandoutNobel
COVID-19 mRNA vaccines: Platforms and current developments
2022
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study
2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
2020
Protein design and variant prediction using autoregressive generative models
2021
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
2021
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Adaptive immunity to SARS-CoV-2 and COVID-19
2021
Efficient evolution of human antibodies from general protein language models
2023
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
2021
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
2021
Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens
2020
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
2022
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
2021
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
2021
Works of Jared Feldman being referenced
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus
2019
COVID-19-neutralizing antibodies predict disease severity and survival
2020
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
2021
Rapid generation of potent antibodies by autonomous hypermutation in yeast
2021
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
2020
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
2022
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
2021